Literature DB >> 24067957

Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection.

Beth McNally1, Fang Ye, Meredith Willette, Emilio Flaño.   

Abstract

In order to maintain the gas exchange function of the lung following influenza virus infection, a delicate orchestration of positive and negative regulatory pathways must be maintained to attain viral eradication while minimizing local inflammation. The programmed death receptor 1 ligand/programmed death receptor 1 (PDL-1/PD-1) pathway plays an important immunoregulatory role, particularly in the context of T cell function. Here, we have shown that influenza virus infection of primary airway epithelial cells strongly enhances PDL-1 expression and does so in an alpha interferon receptor (IFNAR) signaling-dependent manner. PD-1 is expressed primarily on effector T cells in the lung, compared to effector memory and central memory cells, and shortly after influenza virus infection, an increased number of PD-1(+) T cells are recruited to the airways. Using in vitro cocultures of airway epithelial cells and T cells and in vivo models of influenza virus infection, we have demonstrated that blockade of airway epithelial PDL-1 improves CD8 T cell function, defined by increased production of gamma interferon (IFN-γ) and granzyme B and expression of CD107ab. Furthermore, PDL-1 blockade in the airways served to accelerate influenza virus clearance and enhance infection recovery. Our findings suggest that local manipulation of the PDL-1/PD-1 axis in the airways may represent a therapeutic alternative during acute influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067957      PMCID: PMC3838157          DOI: 10.1128/JVI.02423-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

Authors:  Shuang Wei; Andrew B Shreiner; Nobuhiro Takeshita; Lieping Chen; Weiping Zou; Alfred E Chang
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

2.  A critical function for CD200 in lung immune homeostasis and the severity of influenza infection.

Authors:  Robert J Snelgrove; John Goulding; Arnaud M Didierlaurent; Daphne Lyonga; Seema Vekaria; Lorna Edwards; Emily Gwyer; Jonathon D Sedgwick; A Neil Barclay; Tracy Hussell
Journal:  Nat Immunol       Date:  2008-07-27       Impact factor: 25.606

3.  B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.

Authors:  Christian Wahl; Petra Bochtler; Lieping Chen; Reinhold Schirmbeck; Jörg Reimann
Journal:  Gastroenterology       Date:  2008-06-04       Impact factor: 22.682

4.  MUC1 mucin is a negative regulator of toll-like receptor signaling.

Authors:  Keiko Ueno; Takeshi Koga; Kosuke Kato; Douglas T Golenbock; Sandra J Gendler; Hirofumi Kai; K Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-13       Impact factor: 6.914

Review 5.  Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity.

Authors:  Atsushi Kato; Robert P Schleimer
Journal:  Curr Opin Immunol       Date:  2007-10-24       Impact factor: 7.486

Review 6.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

7.  Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.

Authors:  David G Bowen; Naglaa H Shoukry; Arash Grakoui; Michael J Fuller; Andrew G Cawthon; Christine Dong; Dana L Hasselschwert; Kathleen M Brasky; Gordon J Freeman; Nilufer P Seth; Kai W Wucherpfennig; Michael Houghton; Christopher M Walker
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

8.  PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes.

Authors:  Jared H Rowe; Tanner M Johanns; James M Ertelt; Sing Sing Way
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis.

Authors:  Monique Lafon; Françoise Mégret; Sven G Meuth; Ole Simon; Myriam L Velandia Romero; Mireille Lafage; Lieping Chen; Lena Alexopoulou; Richard A Flavell; Christophe Prehaud; Heinz Wiendl
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies.

Authors:  Lowella Heinecke; David Proud; Scherer Sanders; Robert P Schleimer; Jean Kim
Journal:  J Allergy Clin Immunol       Date:  2008-04-18       Impact factor: 10.793

View more
  30 in total

Review 1.  Control of local immunity by airway epithelial cells.

Authors:  M Weitnauer; V Mijošek; A H Dalpke
Journal:  Mucosal Immunol       Date:  2015-12-02       Impact factor: 7.313

2.  Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis.

Authors:  Richard T McKendry; C Mirella Spalluto; Hannah Burke; Ben Nicholas; Doriana Cellura; Aymen Al-Shamkhani; Karl J Staples; Tom M A Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2016-03-15       Impact factor: 21.405

3.  Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.

Authors:  S Yao; L Jiang; E K Moser; L B Jewett; J Wright; J Du; B Zhou; S D Davis; N L Krupp; T J Braciale; J Sun
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

4.  Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.

Authors:  Andrew K Hastings; John J Erickson; Jennifer E Schuster; Kelli L Boyd; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

Review 5.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Multiple Inhibitory Pathways Contribute to Lung CD8+ T Cell Impairment and Protect against Immunopathology during Acute Viral Respiratory Infection.

Authors:  John J Erickson; Meredith C Rogers; Sharon J Tollefson; Kelli L Boyd; John V Williams
Journal:  J Immunol       Date:  2016-06-03       Impact factor: 5.422

Review 7.  Anticancer therapy and lung injury: molecular mechanisms.

Authors:  Li Li; Henry Mok; Pavan Jhaveri; Mark D Bonnen; Andrew G Sikora; N Tony Eissa; Ritsuko U Komaki; Yohannes T Ghebre
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-23       Impact factor: 4.512

Review 8.  Type I interferons in infectious disease.

Authors:  Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

9.  Anti-PD-L1 Therapy Does Not Improve Survival in a Murine Model of Lethal Staphylococcus aureus Pneumonia.

Authors:  Colleen S Curran; Lindsay M Busch; Yan Li; Cui Xizhong; Junfeng Sun; Peter Q Eichacker; Parizad Torabi-Parizi
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

Review 10.  Development of cross-protective influenza a vaccines based on cellular responses.

Authors:  Peter Christiaan Soema; Elly van Riet; Gideon Kersten; Jean-Pierre Amorij
Journal:  Front Immunol       Date:  2015-05-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.